Clearance of platelet microparticles in vivo

A Rank1, R Nieuwland, A Crispin

  • 1Medizinische Klinik III-Grosshadern, Klinikum der Ludwig Maximilians-Universität München, München, Germany. andreas.rank@med.uni-muenchen.de

Platelets
|January 15, 2011
PubMed

Insights

This study tracked platelet-derived microparticles (PMP) clearance in patients after platelet transfusion. PMP levels rapidly increased then decreased, with a half-life of approximately 5.3-5.8 hours.

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Biomedical Science

Background:

  • Platelet-derived microparticles (PMP) are abundant in platelet concentrates.
  • Little is known about PMP clearance in humans due to experimental challenges.

Purpose of the Study:

  • To investigate the kinetics and half-life of transfused PMP in severe thrombocytopenic patients.
  • To understand PMP clearance following platelet transfusion.

Main Methods:

  • Quantified PMP levels using flow cytometry before and after transfusion of apheresis platelet concentrates.
  • Utilized double-staining with annexin V and cell-specific antibodies (anti-CD61, anti-CD63, anti-CD62P).

Main Results:

  • Plasma levels of total microparticles, PMP (CD61+), activated PMP (CD63+), and P-selectin increased immediately post-transfusion.
  • Determined a half-life of 5.8 hours for annexin V-binding microparticles and 5.3 hours for CD61+ PMP.

Conclusions:

  • This study provides the first human data on the half-life of transfused PMP.
  • Transfused PMP exhibit a relatively short half-life in circulation.